•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.How Did AbbVie's Neuroscience Franchise Perform in Q3?
Invest $200,000 in These 5 Dividend Stocks to Fund Your Retirement Income
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
These 3 Dividend Stocks Have Crushed the Market This Year. Here’s Why They Are Still Buys
How Retirees Can Turn $175,000 Into Passive Income With These 4 Dividend Stocks
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
AbbVie Inc. $ABBV Stock Sold by BCV Asset Management Inc.
4 Healthcare Dividend Stocks for Retirees. One Yields Over 4%
5 High-Yield Dividend Stocks That Could Beat a 5% Treasury Yield
3 Dividend Stocks Built for a Market Priced Like It's 1999
How Did AbbVie's Immunology Franchise Fare in Q3?
3 Pharmaceutical Stocks That Offer Safety and Growth
Want a Dividend Check Every Month? This Dividend ETF Paid You 12 Times in the Past Year
ABBV Stock Rises More Than 4% in a Month: Time to Buy, Hold or Sell?
3 Legacy Health Care Dividend Stocks That Never Go Out of Style
AbbVie Inc. $ABBV Stock Bought by AlphaCore Capital LLC
CenterBook Partners LP Purchases New Stake in AbbVie Inc. $ABBV
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications
Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications